INOMIXO is an innovative company dedicated to providing omics solutions for researchers in the field of biopharmaceuticals. Based on advanced mass spectrometry platforms and a team of experienced R&D professionals, INOMIXO has developed two primary business segments, academic omics services and biopharmaceutical CRO services, to create a commercial landscape focused on precise discovery, diagnosis and treatment through multi-omics instrumentation and methodologies.